Free Trial

Guardant Health (GH) News Today

Guardant Health logo
$42.87 -4.53 (-9.56%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$43.12 +0.25 (+0.57%)
As of 02/21/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Guardant Health price target raised to $60 from $55 at BTIG
Guardant Health (GH) Receives a Buy from BTIG
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Posts Earnings Results, Misses Estimates By $0.15 EPS
Guardant Health (NASDAQ:GH - Get Free Report) posted its earnings results on Thursday. The company reported ($0.90) earnings per share for the quarter, missing the consensus estimate of ($0.75) by ($0.15). Guardant Health had a negative return on equity of 1,200.44% and a negative net margin of 74.02%.
Guardant Health, Inc. (GH) Q4 2024 Earnings Call Transcript
Guardant Health options imply 9.3% move in share price post-earnings
Guardant Health Tops Q4 Revenue Forecast
Guardant Health, Inc. stock logo
Baillie Gifford & Co. Reduces Holdings in Guardant Health, Inc. (NASDAQ:GH)
Baillie Gifford & Co. decreased its position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 7.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,449,100 shares of the company's stock after selling 422,9
Guardant Health, Inc. stock logo
Guardant Health, Inc. (NASDAQ:GH) Short Interest Update
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) was the target of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 5,770,000 shares, a drop of 21.6% from the January 15th total of 7,360,000 shares. Based on an average daily volume of 2,160,000 shares, the days-to-cover ratio is currently 2.7 days.
Guardant Health, Inc. stock logo
Guyasuta Investment Advisors Inc. Takes $206,000 Position in Guardant Health, Inc. (NASDAQ:GH)
Guyasuta Investment Advisors Inc. acquired a new stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 6,740 shares of the company's stock, valued at approxim
Guardant Health, Inc. stock logo
Entropy Technologies LP Makes New Investment in Guardant Health, Inc. (NASDAQ:GH)
Entropy Technologies LP purchased a new stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 12,346 shares of the company's stock, valued at approximately $377,000. Other institutional inves
Guardant Health, Inc. stock logo
Guardant Health (GH) Expected to Announce Quarterly Earnings on Thursday
Guardant Health (NASDAQ:GH) will be releasing earnings after the market closes on Thursday, February 20. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=661063)
Guardant Health, Inc. stock logo
Sumitomo Mitsui Trust Group Inc. Grows Position in Guardant Health, Inc. (NASDAQ:GH)
Sumitomo Mitsui Trust Group Inc. lifted its holdings in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 19.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,464,213 shares of the
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Stock Price Down 5.2% - Time to Sell?
Guardant Health (NASDAQ:GH) Trading Down 5.2% - Here's What Happened
Guardant Health, Inc. stock logo
Guardant Health, Inc. (NASDAQ:GH) Stock Holdings Reduced by abrdn plc
abrdn plc cut its position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 19.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 442,951 shares of the company's stock after selling 10
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Shares Gap Down - Time to Sell?
Guardant Health (NASDAQ:GH) Shares Gap Down - Here's Why
Guardant Health Announces Debt Exchange Transactions
Guardant Health, Inc. stock logo
Guardant Health, Inc. (NASDAQ:GH) Receives Average Recommendation of "Buy" from Analysts
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) has been given an average recommendation of "Buy" by the sixteen research firms that are presently covering the company, MarketBeat.com reports. Sixteen equities research analysts have rated the stock with a buy recommendation. The average 1 year
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Shares Down 5.7% - Should You Sell?
Guardant Health (NASDAQ:GH) Trading Down 5.7% - Time to Sell?
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Hits New 52-Week High - Here's What Happened
Guardant Health (NASDAQ:GH) Sets New 1-Year High - Time to Buy?
Guardant Health, Inc. stock logo
Exchange Traded Concepts LLC Decreases Stake in Guardant Health, Inc. (NASDAQ:GH)
Exchange Traded Concepts LLC cut its holdings in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 36.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,010 shares of the
Guardant Health, Inc. stock logo
Guardant Health, Inc. (NASDAQ:GH) Shares Sold by SG Americas Securities LLC
SG Americas Securities LLC lowered its stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 43.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 25,534 shares of the company's stock after selling 19,309 shares du
Guardant Health, Inc. stock logo
The Goldman Sachs Group Raises Guardant Health (NASDAQ:GH) Price Target to $49.00
The Goldman Sachs Group lifted their price target on Guardant Health from $36.00 to $49.00 and gave the stock a "buy" rating in a research note on Tuesday.
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says
The Goldman Sachs Group boosted their price target on shares of Guardant Health from $36.00 to $49.00 and gave the company a "buy" rating in a research report on Tuesday.
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Stock Price Up 6.4% - What's Next?
Guardant Health (NASDAQ:GH) Trading Up 6.4% - What's Next?
Guardant Health initiated with an Overweight at Barclays
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Coverage Initiated at Barclays
Barclays began coverage on shares of Guardant Health in a research report on Thursday. They set an "overweight" rating and a $60.00 target price for the company.
Guardant Health, Inc. stock logo
Q4 EPS Estimates for Guardant Health Increased by Analyst
Guardant Health, Inc. (NASDAQ:GH - Free Report) - Investment analysts at Leerink Partnrs increased their Q4 2024 EPS estimates for shares of Guardant Health in a research report issued to clients and investors on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now anticipates that the com
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Shares Up 6.4% - Here's Why
Guardant Health (NASDAQ:GH) Trading Up 6.4% - Here's Why
Guardant Health, Inc. stock logo
Guardant Health's (GH) "Buy" Rating Reaffirmed at Guggenheim
Guggenheim reiterated a "buy" rating on shares of Guardant Health in a research report on Wednesday.
Guardant Health, Inc. stock logo
Wealthcare Advisory Partners LLC Buys New Shares in Guardant Health, Inc. (NASDAQ:GH)
Wealthcare Advisory Partners LLC purchased a new stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 8,255 shares of the company's stock, valued at ap
Guardant Health price target raised to $55 from $50 at BTIG
Guardant Health: MolDX administrator grants coverage for Guardant Reveal
Get Guardant Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter.

GH Media Mentions By Week

GH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GH
News Sentiment

0.54

0.60

Average
Medical
News Sentiment

GH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GH Articles
This Week

21

7

GH Articles
Average Week

Get Guardant Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:GH) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners